We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

9 hedge funds and large institutions have $689K invested in Zomedica Corp. in 2017 Q4 according to their latest regulatory filings, with 9 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
+9
Holders Change %
–
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
+$432K
2
Millennium Management
Millennium Management
New York
+$136K
3
Citadel Advisors
Citadel Advisors
Florida
+$58K
4
UBS Group
UBS Group
Switzerland
+$8.58K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$4.44K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Cambridge Investment Research Advisors
1
Cambridge Investment Research Advisors
Iowa
$385K +$432K +194,600 New
Millennium Management
2
Millennium Management
New York
$121K +$136K +61,334 New
JA
3
JVL Associates
Michigan
$116K +$130K +58,500 New
Citadel Advisors
4
Citadel Advisors
Florida
$52K +$58K +26,090 New
UBS Group
5
UBS Group
Switzerland
$8K +$8.58K +3,864 New
Royal Bank of Canada
6
Royal Bank of Canada
Ontario, Canada
$4K +$4.44K +2,000 New
Wells Fargo
7
Wells Fargo
California
$3K +$2.83K +1,275 New
Toronto Dominion Bank
8
Toronto Dominion Bank
Ontario, Canada
– +$44 +20 New
Morgan Stanley
9
Morgan Stanley
New York
– +$222 +100 New

ZOM Hedge Fund Activity: Q4 2017 in Review

9 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q4 2017, worth a combined $689K.

Buyers outnumbered sellers: 9 funds opened new ZOM positions and 0 closed out — a net gain of 9 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Cambridge Investment Research Advisors, opening a new position worth an estimated $432K.

  • 9 institutional investors held Zomedica Corp. (ZOM) as of Q4 2017, up from 0 in Q3 2017.
  • Funds reported $689K of Zomedica Corp. stock for Q4 2017.
  • 9 funds opened new Zomedica Corp. positions in Q4 2017 and 0 closed out, a net change of +9 holders.
  • The largest Zomedica Corp. buyer in Q4 2017 was Cambridge Investment Research Advisors, an estimated $432K added.

Based on aggregated 13F filings for Q4 2017.